Cerebral platelet thromboembolism and thromboxane synthetase inhibition

Stroke

Volumn 16, Issue 5, 1985, Pages 800-805

  Fredriksson, K ^a   Rosen I ^a   Johansson, B B ^a   Wieloch, T ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 (3 PYRIDYLMETHYL)PHENYL]METHACRYLIC ACID; ARACHIDONIC ACID; THROMBOXANE SYNTHASE;

ADVERSE DRUG REACTION; ANIMAL EXPERIMENT; AUTOPSY; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD FLOW; CAROTID ARTERY; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; DRUG SENSITIVITY; ELECTROENCEPHALOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NERVOUS SYSTEM; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; RAT; REGIONAL PERFUSION; THROMBOCYTE;

ACRYLATES; ANIMAL; ARACHIDONIC ACIDS; BRAIN; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; ENERGY METABOLISM; EVOKED POTENTIALS, SOMATOSENSORY; HEPARIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; METHACRYLATES; PLATELET AGGREGATION; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; SYNAPTIC TRANSMISSION; THROMBOXANE-A SYNTHASE;

EID: 0021934514     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.16.5.800     Document Type: Article

References (38)

1. Barnett HJM: Platelet and coagulation function in relation to throm-boembolic stroke. In: Advances in Neurology. Thompson RA and Green JR (Eds), Raven Press, New York, 16: 45-70, 1977
2. de Gaetano G, Cerletti C, Bertele V: Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link. Lancet 2: 974-977, 1982
3. Samuelsson B: Prostaglandin endoperoxides and thromboxanes: role asbioregulators. In: the Neurosciences. Fourth study program. Schmitt FO and Worden FG (Eds). MT Press, Cambridge, Massachusetts 1017-1025, 1979
4. Vane JR, Moncada S: Prostacyclin. Ciba Foundation Symposium 71: 79-97, 1980
5. Vermylen J, Carreras LO, Schaeren JV, Defreyn G, Machin SJ, Verstraete M: Thromboxane synthetase inhibition as antithrombotic strategy. Lancet 1: 1073-1075, 1981
6. Verstraete M: A pharmacological approach to the inhibition of platelet adhesion and platelet aggregation. Haemostasis 12: 317-336, 1982
7. Furlow TV, Bass NH: Stroke in rats produced by carotid injection of sodium arachidonate. Science 197: 658-660, 1975
8. Furlow TV, Bass NH: Arachidonate-induced cerebrovascular occlusion intherat. Therole of platelets and aspirin in stroke. Neurology (Minneap) 26: 297-304, 1976
9. Passero S, Battistini N, Fieschi C: Platelet embolism in rabbit brain, Stroke 12: 781-786, 1981
10. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929, 1962
11. Thomgren M, Gustavsson A: Effects of 11-week increase in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 2: 1190-1193, 1981
12. Prior P: Monitoring cerebral functions, long term recordings of cerebral electrical activity. Elsevier/North Holland Biochemical Press, Amsterdam, New York, Oxford, 22-43, 1979
13. Agardh CD, Rosen I: Neurophysiological recovery after hypoglycemic coma in the rat: correlation with cerebral metabolism. J Cereb Blood Flow Metabol 3: 78-85, 1983
14. Ponten U, Ratcheson RA, Salford LG, Siesjo BK: Optimal freezing conditions for cerebral metabolites in rats. J Neurochem 21: 1127-1138, 1973
15. + ratio of the rat brain. J Neurochem 19: 2497-2505, 1972
16. Folbergrova J, Mac Millan V, Siesjo BK: The effect of hypercapnic acidosis upon some glycolytic and Krebs cycle-associated intermediates in the rat brain. J Neurochem 19: 2507-2517, 1972
17. Lowry OH, Passonneau JV: A flexible system of enzymatic analysis. Academic Press, New York, 1972
18. Atkinson DE: The energy charge of the adenylate pool asa regulatory parameter. Interaction with feedback modifiers. Biochemistry, Easton 7: 4030-4034, 1968
19. Ross R: Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis 1: 293-311, 1981
20. 2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thrombosis Research 11: 323-344, 1977
21. Buonassisi V: Sulphated mucopolysaccaride synthesis and secretion in endothelial cell cultures. Expt Cell Res 76: 363-368, 1973
22. Lollar P, Owen WG: Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivationof thrombine by antithrombine III. J Clin Invest 66: 1222-1230, 1980
23. Feinstein MB: The role of calcium in blood platelet function. In: Calcium in Drug Action. Weins GB (Ed), Plenum Press, New York, London, 197-239, 1978
24. 2. Science 209: 1242-1244, 1980
25. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K: The effect of lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg 54: 357-365, 1981
26. Wakai S, AritakeK, Asano T, Takakura K: Selective destruction of the outer leaflet of the capillary endothelial membrane after intra-cerebral injection of arachidonic acid in the rat. Acta Neuropathol (Berl) 58: 303-306, 1982
27. Claesson HE: Prostaglandins and cyclic AMP in platelets and fibroblasts. Thesis, Stockholm, 1979
28. Carreras LO: Thrombosis and thrombocytopaenia induced by heparin. Scand J Haematol 25 suppl 26: 64-80, 1980
29. Anderson WH, Mohammad SF, Chuang HYK, Mason RG: Heparin potentiates synthesis of thromboxane A2 in human platelets. Advances in prostaglandin and thromboxane research 6: 287-291, 1980
30. Niewiarowski S, Rucinski B, James P, Lindahl U: Platelet antiheparin proteins and antithrombin III interact with different binding sites on heparin molecule. FEBS Letters 102: 75-78, 1979
31. 14C) antipyrine. Am J Physiol 234: H59-H66, 1978
32. Abdul-Rahman A, Dahlgren N, Ingvar M, Rehncrona S, Siesjo BK: Local versus regional cerebral blood flow in the rat at high (hypoxia) and low (phenobarbital anaesthesia) flow rates. Acta Physiol Scand 106: 53-60, 1979
33. Branston NM, Symon L, Crockard HA, Pasztor E: Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neural 45: 195-208, 1974
34. Astrup J: Energy-requiring cell functions in the ischemic brain. J Neurosurg 56: 482-497, 1982
35. Branston NM, Ladds A, Wang AD, Symon L: Critical flow thresholds for evoked potentials in thalamus and brainstem. J Cereb Blood Flow Metabol 3 (Suppl 1): S397-S398, 1983
36. Naito J, Ujiie A, Komatsu H et al: Protective effect of OKY:s, TX synthetase inhibitors on thrombosis in rabbit and hypertensive rat models. In: Vth International Conference on Prostaglandins. Florence. Abstract book. Fondazione Giovanni Lorenzini, 774, 1982
37. HirakuS, Wakitani K, Katsube N et al: Pharmacological studies on OKY-1581, the selective thromboxane synthetase inhibitor. In: Vth International Conference on Prostaglandins. Florence. Abstract book. Fondazione Giovanni Lorenzini, 373, 1982
38. Rosenblum WI, El-Sabban F: Effect of OKY-1581, a thromboxane synthesis inhibitor, on the platelet aggregation and vasodilatation induced by injury of mouse pial arterioles. Journal of Cerebral Blood Flow and Metabolism 3: 122-126, 1983